Application of serum anti‑ENO1 and anti‑SSNA1 antibody biomarkers in predicting the prognosis of gastric cancer
Oncology Letters · 22.05.2025 · 30 (1) · 1-11
DOI: 10.3892/ol.2025.15106 ↗Kurz gefasst
Fachartikel in der Zeitschrift Oncology Letters, online erschienen am 22.05.2025. Verfasst von Satoshi Yajima und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterological Surgery, Toho University School of Medicine, Tokyo 143-8541, Japan. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Given the high malignancy of advanced gastric cancer, the identification of biomarkers for the diagnosis and prognosis prediction of advanced gastric cancer is of importance. The present study conducted the serological identification of antigens by recombinant cDNA expression cloning and determined enolase 1 (ENO1) and Sjögren syndrome nuclear autoantigen 1 (SSNA1) as tumor antigens recognized by serum immunoglobulin G (IgG) antibodies in patients with gastric cancer. The clinicopathological significance of preoperative autoantibodies were assessed, namely serum anti-ENO1 antibodies (s-ENO1-Abs) and serum anti-SSNA1 antibodies (s-SSNA-Abs), in the sera of 166 patients with gastric cancer who underwent radical surgery and 96 healthy donors. The s-ENO1-Ab and s-SSNA-Ab titer levels were significantly increased in patients with gastric cancer compared with that in healthy donors (P
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Gastroenterological Surgery, Toho University School of Medicine, Tokyo 143-8541, Japan.
- Department of Clinical Oncology, Toho University Graduate School of Medicine, Tokyo 143-8541, Japan.
- Port Square Kashiwado Clinic, Kashiwado Memorial Foundation, Chiba 260-0025, Japan.
- Department of Neurological Surgery, Graduate School of Medicine, Chiba University, Chiba 260-8670, Japan.
Zitieren
APA
Yajima, S., Ito, M., Suzuki, T., Oshima, Y., Sumazaki, M., Shiratori, F., Takizawa, H., Li, S. Y., Zhang, B. S., Yoshida, Y., Matsutani, T., Hiwasa, T., & Shimada, H. (2025). Application of serum anti‑ENO1 and anti‑SSNA1 antibody biomarkers in predicting the prognosis of gastric cancer. Oncology Letters, 30(1), 1-11. https://doi.org/10.3892/ol.2025.15106
Vancouver
Yajima S, Ito M, Suzuki T, Oshima Y, Sumazaki M, Shiratori F, et al. Application of serum anti‑ENO1 and anti‑SSNA1 antibody biomarkers in predicting the prognosis of gastric cancer. Oncology Letters. 2025;30(1):1-11. doi:10.3892/ol.2025.15106
BibTeX
@article{Yajima2025,
author = {Yajima, Satoshi and Ito, Masaaki and Suzuki, Takashi and Oshima, Yoko and Sumazaki, Makoto and Shiratori, Fumiaki and Takizawa, Hirotaka and Li, Shu-Yang and Zhang, Bo-Shi and Yoshida, Yoichi and Matsutani, Tomoo and Hiwasa, Takaki and Shimada, Hideaki},
title = {Application of serum anti‑ENO1 and anti‑SSNA1 antibody biomarkers in predicting the prognosis of gastric cancer},
journal = {Oncology Letters},
year = {2025},
volume = {30},
number = {1},
pages = {1--11},
doi = {10.3892/ol.2025.15106}
}
EUVIMED